In this talk Dr. Spiera discusses the importance of clinical trials for the development of effective treatments and ultimately a cure. He stresses the value of patients participating in such trials, and describes what the patient's experience might be like.
A Collaboration between HSS and the Scleroderma Foundation"
Juliette Kleinman, LCSW, ACSW and Susan Rodriguez, LCSW
Social Workers Kleinman and Rodriguez created two virtual meetings at the request of the Scleroderma Foundation to help scleroderma patients cope with the effects and affects of Covid19. This talk discusses how the meetings came to be, and how they were received by patients. (To fully understand this talk it is highly recommended for viewers to first view their July 2020 Zoom meeting for patients - see link below) At the 2019 Forum, Ms. Soto-Cardona spoke on the value of Patient Support and Support Groups. This talk updates the prior talk and discusses the impact of Covid19
.
Dr. Gordon discusses the testing process for Scleroderma for diagnosis and beyond - initial testing may determine a classification of the disease, and which parts of the body it is likely to effect, further testing is for prognosis, and for specific manifestations such as GI or Lung Issues.
Dr. Showalter recently joined the team at the Scleroderma Center at HSS. In her talk she discusses her medical education as well as the process of becoming a doctor, and then how she chose scleroderma to be her area of specialization.
Dr. Barrat's talk is a discussion on his current research on scleroderma and the X chromosome in conjunction with a Scleroderma Foundation grant.
Elizabeth Soto-Cardona, MPH
Jessica Gordon, MD
Understanding the
Educational and Training Pathway
of your Scleroderma Doctor"
Kimberly Showalter, MD
Franck Barrat, PhD
[ Return to all Subjects ]